Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview

Eylul Ozgu, Esranur Aydin, Ashkan Adibi, Unal Metin Tokat, Onur Tutar,Jiancheng Hu, Irem Demiray,Razelle Kurzrock,Mutlu Demiray

JCO PRECISION ONCOLOGY(2023)

引用 0|浏览1
暂无评分
摘要
Complete response to Trametinib in a heavily-pretreated sarcoma: RAF1 as a predictor of MEKi Response
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要